Veeva Launches Falcon Safety for Pharmacovigilance
Pleasanton, California, September 1, 2026 Veeva Systems has announced Veeva Falcon Safety, an agentic safety operations product designed to...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Pleasanton, California, September 1, 2026 Veeva Systems has announced Veeva Falcon Safety, an agentic safety operations product designed to...
Raleigh, North Carolina, and Tel Aviv, Israel, September 1, 2026 RedHill Biopharma Ltd. has announced a major expansion of...
Chicago, Illinois, September 1, 2026 Xentria, Inc., a clinical-stage biotherapeutics company, has announced its next-stage clinical development plan for...
Basel, Switzerland, September 1, 2026 Novartis has announced positive topline results from the Phase III REMODEL-1 and REMODEL-2 trials,...
